Copyright
©The Author(s) 2025.
World J Diabetes. Feb 15, 2025; 16(2): 99053
Published online Feb 15, 2025. doi: 10.4239/wjd.v16.i2.99053
Published online Feb 15, 2025. doi: 10.4239/wjd.v16.i2.99053
Figure 6 Plantamajoside downregulates the expression of apoptosis and endoplasmic reticulum stress-related factors in pancreatic tissue of type 2 diabetes mellitus mice and upregulates Dnajc1 expression.
A and B: Impact of plantamajoside (PMS) on apoptosis and the expression of endoplasmic reticulum stress-related proteins in the pancreatic tissue of type 2 diabetes mellitus (T2DM) mice was evaluated using TUNEL staining and Western Blot. After PMS intervention, the TUNEL-positive area in the pancreatic tissue of T2DM mice decreased; C-F: Western blot results showing that expression levels of Bcl-2 increased, while expression levels of Bax and CytC decreased after PMS intervention; G-L: Western blot results showing that expressions of ATF6, XBP1, Ddit3 (CHOP), and GRP78 were downregulated, and expression of Dnajc1 was upregulated after PMS intervention. n = 3 per group. bP < 0.01 vs the normal control group. cP < 0.05, dP < 0.01 vs the T2DM group. PMS-H: Plantamajoside high-dose group.
- Citation: Wang D, Wang YS, Zhao HM, Lu P, Li M, Li W, Cui HT, Zhang ZY, Lv SQ. Plantamajoside improves type 2 diabetes mellitus pancreatic β-cell damage by inhibiting endoplasmic reticulum stress through Dnajc1 up-regulation. World J Diabetes 2025; 16(2): 99053
- URL: https://www.wjgnet.com/1948-9358/full/v16/i2/99053.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i2.99053